loader
Page is loading...
Print Logo Logo
John Cox
OVERVIEW

John W. Cox, Ph.D.

Partner

Atlanta

3340 Peachtree Rd NE
Suite 2900
Atlanta, GA 30326-1092

P 404-264-4092

F 404-264-4033

With deep knowledge of issues facing the life sciences industry, John Cox counsels clients regarding their worldwide intellectual property rights and represents their patent interests when litigation arises, particularly regarding pharmaceutical, chemical, and biotechnology matters. John takes his role in protecting these important assets of life science innovators very seriously while approaching each matter with enthusiasm.

OVERVIEW

With deep knowledge of issues facing the life sciences industry, John Cox counsels clients regarding their worldwide intellectual property rights and represents their patent interests when litigation arises, particularly regarding pharmaceutical, chemical, and biotechnology matters. John takes his role in protecting these important assets of life science innovators very seriously while approaching each matter with enthusiasm.

Through his ability to communicate effectively and succinctly, John advises on, develops, and carries out global IP strategies for the benefit of innovative companies, his clients, who are focused on developing core assets that save and improve the lives of patients. John enjoys leveraging his unique ability to put together targeted and enduring teams for each matter – paying close attention to each person’s strengths and skillsets and how they fit with one another, alongside his highly specialized experience and thoughtful and responsive nature.

John is intimately familiar with the pharmaceutical industry, having dealt with patent and IP subject matter ranging from brain chemistry, the gastrointestinal system, drug delivery systems and treatments of rare diseases and cancer to medical diagnostic methods, the generation of biofuel using bacteria, and processes for manufacturing chemicals and pharmaceutical products. He also has almost two decades of experience in Abbreviated New Drug Application (ANDA) cases, including pre-litigation investigations.

John offers guidance from the first step of a matter through to resolution, including all aspects of litigation. He has extensive experience related to discovery and motion practice, as well as in developing offensive and defensive strategies. He is well versed in dealing with complex subject matter and technical witnesses, such as inventors and experts.

John adeptly helps clients navigate the crossroads of foreign business practices and the complexities of U.S. patent practice, having worked with foreign pharmaceutical, chemical, and biotechnology companies throughout his career.

Honors

The Best Lawyers in America, 2024
EXPERIENCE

{{resultSet.Title}}

  • {{experienceSet.Content}} {{experienceSet.OccuredDateString}} Read More
Presentations
  • Moderator, Legislative Developments Discussion, 2015 Atlanta IP SpringPosium, April 2015
  • Presenter, Seminar on Inequitable Conduct Case Law, 2013 BIO IP Counsels Committee Conference, March 2013
  • Moderator of Case Law Discussion, 2012 BIO IP Counsels Committee Conference, April 2012
  • Dissertation Research Presentation, Seminar on The Study of Interactions between Multinuclear Platinum Complexes and DNA with a Focus on Ligands, Linker Groups, and Kinetics: A Molecular Modeling and NMR Study, Virginia Commonwealth University, March 2000 

These presentations occurred prior to joining Barnes & Thornburg.

Publications
  • “Considerations for Leveraging IP in the Life Sciences Sector,” National Law Review, March 3, 2020
  • “Sections 101 and 112: Eligibility, Patentability, or Somewhere in Between?,” IP Watchdog, March 22, 2017
  • Co-author, “A Brief History of Supreme Court Interest in Patent-Eligible Subject Matter Under 35 U.S.C. § 101,” University of Florida Journal of Technology Law and Policy, 2014
  • Quoted, “Decision May Spur Innovation, Put Other Firms' Patents at Risk, Specialty Pharmacy News,” July 2013
  • Quoted, “Scalia Won't Sign Off On DNA Science In Gene Ruling,” Law360, June 13, 2013
  • Quoted, “Attorneys React To High Court's Gene Patent Ruling,” Law360, June 13, 2013
  • Co-author, “The Supreme Court is Paying Attention to Patent Law Again,” Law360, April 1, 2013
  • “Biotech Patent Case Law Updates at the IPCC,” BIOtechNOW, May 1, 2012
  • Co-author, “Kinetic Analysis of the Stepwise Formation of a Long-range DNA Interstrand Cross-link by a Dinuclear Platinum Antitumor Complex: Evidence for Aquated Intermediates and Formation of Both Kinetically and Thermodynamically Controlled Conformers,” Am. Chem. Soc., 2001,123 (7), 1316-1326

These publications occurred prior to joining Barnes & Thornburg.

INSIGHTS & EVENTS
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.